Investing in frontier technologies that elevate mental health and wellness.
Psychedelics & New Compounds
Neurotech & BCI
We are a community-focused fund & syndicate that provides capital and support to the best and most innovative companies that align healing, responsibility, and profitability. We can end mental illnesses.
We invest in new categories that will revolutionize how mental health is treated.
& NEW COMPOUNDS
Psychedelics (i.e. psilocybin, MDMA, DMT, ketamine) or novel compounds to treat conditions including depression, addiction, PTSD, and more.
Direction connection of technical components with the brain and nervous system are addressing mental health disorders and neurological diseases
Paradigm of clinical care shifting from general approach for large populations to individual-based deep knowledge of clinical and biological characteristics
Software applications that help patients treat, prevent, or manage a disease, and have a proven clinical benefit
Interconnection of biology, psychology, environment, and lifestyle, aiming to address root causes and promote overall well-being
Bidirectional relationship between metabolic processes and mental health, through diet, exercise, and gut microbiota can impact brain function and psychiatric disorders.
Mobile applications, wearables, and online platforms that enable remote access to mental health services, and facilitate data-driven personalized care
Advanced algorithms and machine learning to analyze vast data to enable early detection, accurate diagnosis, drug development and personalized treatment
Non-invasive treatment for mental health
Marketplace for transformational mental health modalities
Transcranial-electric stimulation for mental health
STEALTH ARTIFICIAL INTELLIGENCE
AI-assisted therapy tool for therapists
We're donating 4.19% of our profit to psychedelic non-profits and indigenous communities since we are standing on the shoulders of giants.
Greg is a community builder, investor, founder. He is a co-host of Business Trip, a podcast about psychedelic entrepreneurship. Over 15 investments in psychedelic medicine and mental health companies. Co-founded HelloSponsor, a SaaS sponsorship platform (AngelPad '15). Ex-Morgan Stanley, Viacom.
Matias is an investor, founder, operator and startup ecosystem builder. He previously led NVIDIA Inception North America, a startup accelerator for AI companies. Before that, he co-founded CookUnity, raising $23m from Collaborative Fund, IDC Ventures, and others. Matias is the co-host of Business Trip.
Dina was one of the first investors in psychedelic therapeutics space and
is on the founding team of the largest psychedelic research center. Dina is also a serial entrepreneur, angel investor (Coinbase, Boom Supersonic, Mattermost), ex-McKinsey / J.P. Morgan, MBA Harvard Business School and MS in Psychology at CIIS.
Caitlin is a chief of staff, community builder, and operator. She previously executed growth and operations at Cerebral and alternative investing and asset management at BlackRock. 9 years of mental health event management and project development. Caitlin is ex-Harvard in Economics and Computer Science.